Zephyr AI Email Format
Biotechnology ResearchVirginia, United States11-50 Employees
Zephyr AI is a biotechnology research company based in Tysons Corner, Virginia. It uses large, complex datasets and proprietary analytics to uncover insights across precision medicine, drug discovery, drug rescue, and clinical decision support. The company partners with health systems, health plans, and biotechnology pioneers to improve care quality, patient outcomes, and cost efficiency. As a relatively small organization, it focuses on translating data-driven findings into clinically and scientifically actionable decisions. Zephyr AI primarily targets oncology and cardiometabolic diseases, aiming to support treatment decisions and monitor responses. A notable recent development is a collaboration with Guardant Health announced in 2025 to integrate Guardant's DNA repository with Zephyr AI’s capabilities to derive cancer biomarker insights for targeted therapy selection and monitoring.